Company
Every investor coverage indicates participated in a round University at Buffalo raised.
Companies University at Buffalo acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Elad Levy | Chair of Neurosurgery | Forbes Australia |
Stories naming University at Buffalo. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Australian neurotech firm Synchron reported year-long trial results showing its brain implant was safe in six US patients, including one who used Amazon's Alexa by thought alone, keeping it ahead of Musk's Neuralink.